The North American PDX Models Market (2018-2025): Company Profiles, Size, Share, Growth, Trends and Segment Forecasts - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 28, 2018--The “North America PDX Models Market - Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering.
North America PDX models market is expected to hold the leading market share in the forecast period of 2018 to 2025.
Prominent factors driving the growth of this market consist of rising number of pharmaceutical R&D activities in cancer research, advantages offered by PDX models offer compared with the classic approach, rising need for personalized medicine and increasing support for cancer research activities from government and non-government organization.
The North America PDX models market is segmented based on type into two notable segments; mice models and rat models. In 2018, mice models segment is valued to rule with the highest market share by 2025.
The North America PDX models market is segmented in tumor type categories into six notable segments; respiratory tumor models, urological tumor models, gastrointestinal tumor models, hematological tumor models, gynecological tumor models and others. In 2018, respiratory tumor models segment is valued to rule with the highest market shares by 2025, rising at the highest CAGR.
The North America PDX models market is segmented in application into preclinical drug development and oncology research and biomarker analysis. In 2018, preclinical drug development and oncology research segment is valued to rule with highest market shares and rising at the highest CAGR.The North America PDX models market is segmented in end user into contract research organization (CRO), academic and research institutions and pharmaceutical and biotechnology companies. In 2018, contract research organization (CRO) segment is valued to rule with highest market shares and rising at the highest CAGR.Key PlayersCrown Bioscience Inc.The Jackson LaboratoryChampion Oncology Inc.Charles RiverOncodesignWuxi AppTecHorizon Discovery Group plcPharmatest ServicesHera BiolabsEPO Berlin-Buch GmbHXentechUroleadCreative AnimodelEUROPDXMI Bioresearch Inc.Aragen Bioscience
Key Topics Covered
2 Market Segmentation
3 Market Overview
4 Executive Summary
5 Premium Insights
6 North America PDX Models Market, by Type
7 North America PDX Models Market, by Tumor Type
8 North America PDX Models Market, by Application
9 North America PDX Models Market, by End User
10 North America PDX Models Market, by Geography
11 North America PDX Models Market, Company Landscape
12 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/wnlmnx/the_north?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180928005578/en/
Laura Wood, Senior Manager
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Drug Discovery
KEYWORD: NORTH AMERICA
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/28/2018 03:29 PM/DISC: 09/28/2018 03:29 PM